Chronic heart failure (CHF) is a challenging burden on public health. Therapeutic strategies
for CHF have developed rapidly in the past decades from conventional medical therapy …

Nowadays, guidelines are derived from the findings of randomized controlled therapeutic
trials. However, an overall significant P value does not exclude that some patients may be …

The existing data regarding the role of QRS duration (QRSd) change on cardiac
resynchronization therapy (CRT) response show some inconsistent results. We conducted a …

Background There are limited data about cardiac resynchronization therapy (CRT) in adult
congenital heart disease. We aimed to assess early and late outcomes of CRT among …

Background: The mouse is the most widely used mammal in experimental biology. Although
many clinically relevant in vivo cardiac stressors are used, one that has eluded translation is …

Background Cardiac resynchronization therapy (CRT) may improve secondary mitral
regurgitation (MR) in patients with cardiomyopathy. The effects on mitral valve (MV) and left …

Background Cardiac resynchronization therapy (CRT) is efficacious in the treatment of
chronic heart failure (CHF); however, because it is non-physiological, some patients are …

Objective To evaluate left univentricular (LUV) pacing for cardiac resynchronization therapy
(CRT) using a rate-adaptive atrioventricular delay (RAAVD) algorithm to track physiological …

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis …

Cardiac resynchronization therapy (CRT) has clearly been established as a mainstay
therapy for patients with congestive heart failure (CHF), New York Heart Association …